Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1325, 2002-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etanercept of greater value than adalimumab or infliximab for RA
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :
Etanercept of greater value than adalimumab or infliximab for RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. :
Infliximab, etanercept worthwhile for RA in Spain?
Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. :
Infliximab for Crohn's disease perianal fistulae discussed
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 366, 2002-01 ,pp. :